Remove 2007 Remove FDA Remove Vaccines
article thumbnail

PFAS Exposure Tied to Greater Weight Regain After Adolescent Bariatric Surgery

Pharmacy Times

Image Credit: Grandbrothers | stock.adobe.com The study looked at 186 adolescents from the Teen-LABS group who had bariatric surgery between 2007 and 2012. This research shows how the environment plays a role in the results of weight surgery in young people over time.¹

article thumbnail

EpiPen patent expiry opens new era for innovation

Pharmaceutical Technology

Using real-world data to support vaccine outreach and education Buy Reports Newsletters PT News EpiPen patent expiry opens new era for innovation The expiration of Viatris’s EpiPen patent in September 2025 will likely result in increased competition and lower costs in the epinephrine delivery space.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sustainable Alternative: PFAS-Free-TPE for Pharmaceutical Stoppers

PharmTech

Needle of a syringe protrudes through the rubber cap of a vaccine vial with red cap. Toward a New Comprehensive Global Database of Per- and Polyfluoroalkyl Substances: Summary Report on Updating the OECD 2007 List of. OECD Environment Directorate. Chemicals and Biotechnology Committee. 2018 (accessed October 2023). Fraunhofer.

article thumbnail

CDC Report Finds No Connection Between Thimerosal and Autism

Drug Topics

In a new CDC report, investigators found that there was no connection between thimerosal in vaccines and autism or other neurodevelopmental conditions. The properties of thimerosal were documented to contribute to the safe use of multidose vials and packaging of vaccines, such as seasonal and pandemic influenza vaccines.

article thumbnail

From Pasteur to Present: Historical and Contemporary Perspectives on Publication Bias in Scientific Literature

Pharmacy Times

A frequently cited example is the 1881 anthrax vaccine demonstration at Pouilly-le-Fort, which Pasteur publicly described as a success resulting from oxygen attenuation techniques. However, his private notebooks reveal a more complex process characterized by trial and error, methodological changes, and episodes of uncertainty.

article thumbnail

ICH Q6(R1): test criteria and specifications

European Pharmaceutical Review

The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA. EMA/CHMP/ICH/214732/2007. Internet] Vaccines Europe. EU Official Says ICH Q6B Is Outdated And Needs Revision. Internet] Regulatory Focus. cited 2024August]. Available from: [link] 4. Pharmaceutics. 2021; 13(1): 48. 22 June 2017. 3 February 2023.

article thumbnail

First continuous mRNA manufacturing platform to be developed

European Pharmaceutical Review

The $82 million project is funded by the US Food and Drug Administration (FDA) Center for Biologics Evaluation and Research. This $85 million programme ran between 2007 and 2019. This new pilot-scale system builds on success of the Novartis-MIT Center for Continuous Manufacturing.

FDA